SHL Medical is keeping a step ahead as we face the new normal, implementing measures that look forward to an evolved way of working.
SHL Medical, a pioneer and technology frontrunner in the self-injection industry, announced its acquisition of Weibel CDS, a medical technology company offering products and solutions for drug delivery and novel packaging.
SHL Medical has taken proactive measures to protect the health of our colleagues and ensure the continuity of business operations.
Innovation Zed Ltd., a developer of connected health solutions, entered into a commercial partnership with diagnostics company A. Menarini Diagnostics.
SHL will exhibit at Pharmapack Europe 2020 between February 5-6 in Paris, France.
On November 5, SHL Group, a global leader in the design, development, and manufacturing of drug delivery devices, held the inauguration of its new Liufu site in Taoyuan City, Taiwan.
SHL is set on presenting its strong pipeline of autoinjectors designed for high volume and high viscosity drug formulations.
SHL Group announced plans to create 800 new jobs in Taiwan to support ramped up productions for SHL Medical.
Capitalizing on Taiwan’s advanced position in electronics and software development, the company also aims to set up an incubator to establish its footprint in the digital healthcare industry.